Allurion Technologies (ALURW) Cash from Investing Activities (2022 - 2024)
Allurion Technologies (ALURW) reported Cash from Investing Activities of -$72000.0 for Q3 2024, up 91.0% on a YoY basis from -$37696.3 in Q4 2023, and up 83.45% quarter-over-quarter from -$435000.0 in Q2 2024.
Allurion Technologies (ALURW) Cash from Investing Activities (2022 - 2024) Analysis & Trends
Allurion Technologies has reported Cash from Investing Activities for 3 years, with the latest figure at -$72000.0 in Q3 2024.
- For the quarter ending Q3 2024, Cash from Investing Activities rose 91.0% year-over-year to -$72000.0; the trailing twelve-month figure through Dec 2024 stood at -$611000.0 (up 61.96% YoY), and the FY2024 full-year result was -$611000.0, up 61.96% from the prior year.
- Cash from Investing Activities for Q3 2024 stood at -$72000.0, up from -$435000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $157000.0 in Q3 2022, with the low at -$800000.0 in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$279888.9 across 3 years, with a median of -$277000.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities plunged 609.55% — and 2024, when it surged 91.0%.
- Allurion Technologies' Cash from Investing Activities stood at -$459000.0 in 2022, then increased by 13.29% to -$398000.0 in 2023, then jumped by 81.91% to -$72000.0 in 2024.
- The last three Cash from Investing Activities figures came in at -$72000.0 (Q3 2024), -$435000.0 (Q2 2024), and -$104000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -72,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -435,000.00 |
| Jun 30, 2024 | -435,000.00 |
| Mar 31, 2024 | -104,000.00 |
| Mar 31, 2024 | -104,000.00 |
| Dec 31, 2023 | -398,000.00 |
| Dec 31, 2023 | -398,000.00 |
| Sep 30, 2023 | -800,000.00 |
| Sep 30, 2023 | -800,000.00 |
| Jun 30, 2023 | -131,000.00 |
| Jun 30, 2023 | -131,000.00 |
| Mar 31, 2023 | -277,000.00 |
| Mar 31, 2023 | -277,000.00 |
| Dec 31, 2022 | -459,000.00 |
| Dec 31, 2022 | -459,000.00 |
| Sep 30, 2022 | 157,000.00 |
| Sep 30, 2022 | 157,000.00 |